ASXL1 and atypical chronic myeloid leukemia, BCR-ABL1 negative: aCML is characterized by recurrent somatic mutations in SETBP1, ASXL1, and ETNK1 genes, as well as high genetic heterogeneity [11,12], although their prognostic impact remains unclear.